Osteoporosis is a skeletal disease characterized by decreased bone density and increased fragility due to disruption of bone tissue metabolism with predominance of catabolism over bone formation processes, reduced bone strength, and increased fracture risk.

Those most commonly affected by osteoporosis:

• People of Caucasian or Mongoloid race

• Close relatives of osteoporosis patients or those who have sustained pathological fractures and/or hip and vertebral fractures

• Elderly and advanced-age individuals

• Women (osteoporosis risk in men is three times lower than in women)

• People with low body weight (under 56 kg for Caucasian women, under 50 kg for Asian women, under 70 kg for men of both races)

• People with critical height (for women - above 172 cm, for men - 183 cm)

Causes of Osteoporosis:

• Any hormonal imbalance

• Infrequent sexual activity

• Early menopause

• All types of infertility

• Smoking

• Alcohol abuse

• Adynamia, insufficient physical activity

• Excessive physical exertion

• Dietary calcium deficiency (mineral deficiency in diet or impaired absorption)

• Vitamin D hypovitaminosis (vitamin deficiency in diet or residence in northern regions)

Comorbid conditions that may cause osteoporosis:

• Hyperparathyroidism, thyrotoxicosis, hyperprolactinemia, diabetes mellitus

• Blood and hematopoietic organ diseases

• Rheumatoid arthritis, Bekhterev's disease, polymyositis, systemic lupus erythematosus

• Digestive system disorders (malabsorption)

• Chronic circulatory insufficiency

• Chronic renal failure

• Post-organ transplantation status

Osteoporosis may be caused by long-term use of medications:

• Glucocorticoids (prednisolone equivalent ≥ 7.5 mg/day for six months or more)

• Thyroid hormones (L-thyroxine, etc.)

• Anticoagulants

• Cancer treatment agents (cytostatics, cytotoxins)

• Methotrexate, cyclosporine A

• Tetracycline antibiotics

• Phosphate-binding antacids

Package - Treatment of Osteoporosis

• Diagnostic examination by the treating physician, thermometry, identification of inflammatory or degenerative processes.

• Development of an individualized treatment program, accounting for all comorbidities.

• Creation of an individualized diet based on urine and blood test results.

• Application of turpentine baths (Prof. Zalmanov) to improve blood flow in bone tissues.

• Use of dietary supplements based on minerals and fatty acids for bone strengthening.

• When necessary, additional procedures are performed to treat comorbid conditions.

• Additional procedures as needed.

• Preparation of a home treatment plan following completion of treatment at the clinic.

• Conducting a final physician examination upon completion of the treatment course.